Optimization of transgene expression in mammalian cells
CA 2483050 A1 · Owner: Faucon-Biguet, Nicole · Inventors: Brun, Sophie; Dufour, Noelle; Faucon-Biguet, Nicole
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to vectors compositions and methods for , delivering transgenes into mammalian cells. The invention also relates to genetic constructs and recombinant cells suitable to produce such transgenes. The invention more particularly relates to a vector suitable for transgene delivery into mammalian cells, wherein said vector comprises a chimeric genetic construct comprising a transgene operably linked to at least two distinct posttranscriptional regulatory elements functional in mammalian cells. This invention can be used in experimental research, therapeutic, prophylactic or diagnostic areas.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 29, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 29, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 29, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.